Please Wait.....
Report
Middle East & Africa Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray)
Market Report I 2022-10-07 I 116 Pages I The Insight Partners
The influenza vaccines market in Middle East & Africa is expected to grow from US$ 374.35 million in 2022 to US$ 533.85 million by 2028. It is estimated to grow at a CAGR of 6.1% from 2022 to 2028.
Strong Pipeline Candidates for Influenza Vaccines
Leading players in the influenza vaccines market have multiple projects on drug delivery and biological pipelines based on proprietary technology. The most advanced candidate population in drug delivery completed 2 Phase I studies. The pipeline also includes a large number of compounds that have completed preclinical evaluation. Pipeline candidates are focused on unlocking the science of the immune system, human genetics, and cutting-edge technologies to develop innovative vaccines. Companies are investing in scientific and technical excellence to develop and introduce new vaccines and specific drugs against infectious diseases, including influenza. Vaccines and viral therapeutic candidates in the pipeline are capable of rapidly and specifically responding to the most pressing health threats.
Market Overview
The Middle East & Africa Influenza Vaccines Market is categorized into the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. In 2021, South Africa was the largest market for Influenza Market in the region. The market for Influenza Market in the Middle East & Africa is anticipated to grow at a CAGR of 6.1% during the forecast period The influenza vaccines market is expected to grow due to the huge population base, increasing cases of influenza, and growing research studies across the region. Moreover, growing healthcare facilities help propel the market growth. Saudi Arabia is one of the important countries in the Middle Eastern region that has significant scope for the influenza vaccines market. The healthcare system in the country is developing at a rapid pace as well as increasing number of international companies are developing medical and research teams in the country. A sharp increase in the state health budget is also expected to drive the growth of the influenza vaccines market in the country.
Saudi Arabia is among the fastest growing regions in the Middle East & Africa whose growth is driven by a huge population base with chronic diseases. According to the latest WHO data published in 2020 Influenza and Pneumonia Deaths in Saudi Arabia reached 6,132 or 4.58% of total deaths. The age-adjusted Death Rate is 30.87 per 100,000 of population ranks Saudi Arabia 82 in the world. In 2009, in response to the pandemic Influenza A(H1N1)pdm09, the public health department at the Ministry of Health in Saudi Arabia established its first case-based Influenza surveillance system. In Saudi Arabia, rising healthcare spending and well-established hospital and tertiary care centers fuel the growth of the market. The government has increased healthcare and social affairs expenditure by 48% to US$ 42.64 billion (SR160bn) for the development of new healthcare centers, hospitals, and primary care centers. Thus, such initiatives by the government, and penetration of international market players are expected to drive the growth of influenza vaccines market in Saudi Arabia.
Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Influenza Vaccines Market Segmentation
The Middle East & Africa Influenza Vaccines Market is segmented into vaccine type, virus type, technology, route of administration, and country.
Based on vaccine type, the Middle East & Africa influenza vaccines market is divided into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment registered the larger market share in 2022.
Based on virus type, the Middle East & Africa influenza vaccines market is segmented into influenza virus type A and influenza virus type B. The influenza virus type A segment held a larger market share in 2022.
Based on technology, the Middle East & Africa influenza vaccines market is divided into egg-based and cell-based. The egg-based segment held a larger market share in 2022.
Based on route of administration, the Middle East & Africa influenza vaccines market is divided into injection and nasal spray. The injection segment held a larger market share in 2022.
Based on country, the market is segmented into the UAE, Saudi Arabia, South Africa, and the rest of Middle East & Africa. Saudi Arabia dominated the market share in 2022.
AstraZeneca; GlaxoSmithKline plc.; Hualan Biological Engineering Inc.; Mitsubishi Chemical Group Corporation; MYLAN N.V.; Sanofi; SEQIRUS; and Serum Institute of India Pvt. Ltd are the leading companies operating in the influenza vaccines market in Middle East & Africa.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Influenza Vaccines Market - By Vaccine Type
1.3.2 MEA Influenza Vaccines Market - By Virus Type
1.3.3 MEA Influenza Vaccines Market - By Technology
1.3.4 MEA Influenza Vaccines Market - By Route Of Administration
1.3.5 MEA Influenza Vaccines Market - By Country
2. MEA Influenza Vaccines Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Influenza Vaccines Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 MEA PEST Analysis
4.3 Experts Opinion
5. MEA Influenza Vaccines Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Government Support to Promote Influenza Vaccination
5.2 Market Restraints
5.2.1 High Cost of Vaccine Development
5.3 Market Opportunities
5.3.1 Emerging Economies
5.4 Future Trends
5.4.1 Strong Pipeline Candidates for Influenza Vaccines
5.5 Impact Analysis
6. Influenza Vaccine Market - MEA Analysis
6.1 MEA Influenza Vaccines Market Revenue Forecasts And Analysis
7. MEA Influenza Vaccines Market- By Vaccine Type
7.1 Overview
7.2 MEA Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)
7.3 Quadrivalent Vaccines
7.3.1 Overview
7.3.2 MEA Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Trivalent Vaccines
7.4.1 Overview
7.4.2 MEA Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8. MEA Influenza Vaccines Market- By Virus Type
8.1 Overview
8.2 MEA Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)
8.3 Influenza Virus Type A
8.3.1 Overview
8.3.2 MEA Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Influenza Virus Type B
8.4.1 Overview
8.4.2 MEA Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9. MEA Influenza Vaccines Market - By Technology
9.1 Overview
9.2 MEA Influenza Vaccines Market, By Technology 2022 & 2028 (%)
9.3 Egg-Based
9.3.1 Overview
9.3.2 MEA Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Cell-Based
9.4.1 Overview
9.4.2 MEA Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10. MEA Influenza Vaccines Market- By Route of Administration
10.1 Overview
10.2 MEA Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)
10.3 Injection
10.3.1 Overview
10.3.2 MEA Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Nasal Spray
10.4.1 Overview
10.4.2 MEA Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11. MEA Influenza Vaccines Market - Country Analysis
11.1 MEA Influenza Vaccine Market Revenue and Forecasts To 2028
11.1.1 Overview
11.1.2 MEA: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
11.1.2.1 Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.1 Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.2 Saudi Arabia: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
11.1.2.1.3 Saudi Arabia: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
11.1.2.1.4 Saudi Arabia Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.5 Saudi Arabia Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
11.1.2.2 UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.1 UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.2 UAE: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
11.1.2.2.3 UAE: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
11.1.2.2.4 UAE Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.5 UAE Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
11.1.2.3 South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.1 South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.2 South Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
11.1.2.3.3 South Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
11.1.2.3.4 South Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.5 South Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
11.1.2.4 Rest of MEA: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.4.1 Rest of MEA: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.4.2 Rest of MEA: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
11.1.2.4.3 Rest of MEA: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
11.1.2.4.4 Rest of MEA: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
11.1.2.4.5 Rest of MEA: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
12. MEA Influenza Vaccine Market -Industry Landscape
12.1 Overview
12.2 Inorganic Growth Strategies
12.2.1 Overview
12.3 Organic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 SEQIRUS
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Sanofi
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Hualan Biological Engineering Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Mitsubishi Chemical Group Corporation
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Serum Institute of India Pvt. Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 MYLAN N.V.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AstraZeneca
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. MEA Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. Saudi Arabia Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia Influenza Vaccine Market, by Virus Type- Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 6. UAE Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 7. UAE Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 8. UAE Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 9. UAE Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 10. South Africa Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 13. South Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of MEA Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of MEA Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of MEA Influenza Vaccine Market, by Technology- Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of MEA Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 18. Recent Inorganic Growth Strategies in the MEA Influenza Vaccine Market
Table 19. Recent Organic Growth Strategies in the MEA Influenza Vaccine Market
Table 20. Glossary of Terms, MEA Influenza Vaccines Market
LIST OF FIGURES
Figure 1. MEA Influenza Vaccines Market Segmentation
Figure 2. MEA Influenza Vaccines Market Segmentation, by Country
Figure 3. MEA Influenza Vaccines Market Overview
Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in MEA Influenza Vaccines Market
Figure 5. Saudi Arabia Is Expected to Show Remarkable Growth During the Forecast Period
Figure 7. MEA: PEST Analysis
Figure 8. Experts Opinion
Figure 9. Impact Analysis
Figure 10. MEA Influenza Vaccines Market - Revenue Forecasts and Analysis - 2020- 2028
Figure 11. MEA Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)
Figure 12. MEA Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. MEA Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. MEA Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)
Figure 15. MEA Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. MEA Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. MEA Influenza Vaccines Market, by Technology 2022 & 2028 (%)
Figure 18. MEA Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. MEA Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. MEA Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)
Figure 21. MEA Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. MEA Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. MEA: Influenza Vaccine Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. MEA: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
Figure 25. Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 26. UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 27. South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
Figure 28. Rest of MEA: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security